News & Updates

Show Multimedia Only

Bladder problems burden people with multiple sclerosis

Bladder dysfunction is among the top 10 most frequently reported functional domains affecting people living with multiple sclerosis (MS), reports a study presented at EAU 2026.

Bladder problems burden people with multiple sclerosis

23 hours ago

Acid suppressant use tied to risk of ischaemic events in stroke patients on clopidogrel

24 Mar 2026

Acid suppressants such as potassium-competitive acid blockers (P-CABs) and proton pump inhibitors (PPIs), when used concomitantly with clopidogrel, carry an increased risk of ischaemic events in stroke patients, according to a retrospective cohort study.

Acid suppressant use tied to risk of ischaemic events in stroke patients on clopidogrel

24 Mar 2026

Novel antisense oligonucleotide shows disease-modifying potential in Dravet syndrome

21 Mar 2026 by

In children with Dravet syndrome, treatment with the investigational antisense oligonucleotide zorevunersen appears safe and efficacious, with seizure frequency reductions of up to 90 percent and improvements in nonseizure symptoms, according to two phase 1–2a studies (MONARCH and ADMIRAL) and the corresponding open-label extension studies (SWALLOWTAIL and LONGWING).

Novel antisense oligonucleotide shows disease-modifying potential in Dravet syndrome

21 Mar 2026

Xanomeline-trospium chloride combo safe, effective in schizophrenia

20 Mar 2026

Treatment with xanomeline and trospium chloride (X/T) over 52 weeks appears safe and well tolerated, demonstrating durable symptom improvements in individuals with schizophrenia, reports a study.

Xanomeline-trospium chloride combo safe, effective in schizophrenia

20 Mar 2026

Smartwatch enhances AF detection in patients at risk of stroke

18 Mar 2026

The use of a smartwatch-based atrial fibrillation (AF) screening results in improved detection rates of new-onset AF relative to standard care in patients at increased risk of stroke, reports a study.

Smartwatch enhances AF detection in patients at risk of stroke

18 Mar 2026

Gout not a risk factor for dementia

17 Mar 2026

Gout does not contribute to an increased risk of overall dementia and may even be protective against Alzheimer's disease (AD) and cognitive impairment, according to the results of a systematic review and meta-analysis.

Gout not a risk factor for dementia

17 Mar 2026

Intensive BP-lowering strategy does not harm cognitive function

13 Mar 2026

In Chinese hypertensive patients, lowering systolic blood pressure (BP) to a target of <120 mm Hg for 3 years appears to have no adverse effect on cognitive function, according to a study.

Intensive BP-lowering strategy does not harm cognitive function

13 Mar 2026

Healthy eating linked to lower stroke risk

12 Mar 2026

For individuals at high risk of cardiovascular disease (CVD), adherence to healthy dietary patterns confers stroke protection, as reported in a study.

Healthy eating linked to lower stroke risk

12 Mar 2026

Air pollution ups risk of Alzheimer’s disease

11 Mar 2026 by

Exposure to fine particulate matter PM2.5 may elevate the risk for Alzheimer’s disease (AD), mainly through direct pathways instead of mediation by common comorbidities, suggests a study.

Air pollution ups risk of Alzheimer’s disease

11 Mar 2026

Angiotensin-II stimulating agents associated with lower burden of key AD neuropathologies

11 Mar 2026 by

Cumulative angiotensin II–stimulating (vs angiotensin II–inhibiting) antihypertensive exposure is associated with lower risk of certain dementia-related neuropathologies, a US study has found.

Angiotensin-II stimulating agents associated with lower burden of key AD neuropathologies

11 Mar 2026

News & Updates

Showing Neurology articles

Showing

Specialty:

Bladder problems burden people with multiple sclerosis

Bladder problems burden people with multiple sclerosis

Acid suppressant use tied to risk of ischaemic events in stroke patients on clopidogrel

Acid suppressant use tied to risk of ischaemic events in stroke patients on clopidogrel

Novel antisense oligonucleotide shows disease-modifying potential in Dravet syndrome

Novel antisense oligonucleotide shows disease-modifying potential in Dravet syndrome

Xanomeline-trospium chloride combo safe, effective in schizophrenia

Xanomeline-trospium chloride combo safe, effective in schizophrenia

Smartwatch enhances AF detection in patients at risk of stroke

Smartwatch enhances AF detection in patients at risk of stroke

Gout not a risk factor for dementia

Gout not a risk factor for dementia

Intensive BP-lowering strategy does not harm cognitive function

Intensive BP-lowering strategy does not harm cognitive function

Healthy eating linked to lower stroke risk

Healthy eating linked to lower stroke risk

Air pollution ups risk of Alzheimer’s disease

Air pollution ups risk of Alzheimer’s disease

Angiotensin-II stimulating agents associated with lower burden of key AD neuropathologies

Angiotensin-II stimulating agents associated with lower burden of key AD neuropathologies